[Treatment of bronchial asthma].
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D001991:Bronchitis / Q000150:complications; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002908:Chronic Disease; D004809:Ephedrine / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D007478:Iontophoresis; D007545:Isoproterenol / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D011014:Pneumonia / Q000150:complications; D011621:Pteridines / Q000627:therapeutic use; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D011941:Receptors, Adrenergic / Q000187:drug effects; D012852:Sinusitis / Q000150:complications; D013726:Terbutaline / Q000627:therapeutic use; D014069:Tonsillitis / Q000150:complications
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D002301:Cardiac Glycosides; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D011621:Pteridines; D011941:Receptors, Adrenergic; D000628:Aminophylline; D009921:Metaproterenol; D005665:Furosemide; D004809:Ephedrine; D007545:Isoproterenol; D004976:Ethacrynic Acid; D013726:Terbutaline; D000420:Albuterol
Lechenie bronkhial'noĭ astmy